Elhissi A - Search Results

1

Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles.

Kawish M, Elhissi A, Jabri T, Iqbal KM, Zahid H, Shah MR. Kawish M, et al. Among authors: elhissi a. Pharmaceutics. 2020 May 28;12(6):492. doi: 10.3390/pharmaceutics12060492. Pharmaceutics. 2020. PMID: 32481715 Free PMC article.

2

A comprehensive production method of self-cryoprotected nano-liposome powders.

Gala RP, Khan I, Elhissi AM, Alhnan MA. Gala RP, et al. Among authors: elhissi am. Int J Pharm. 2015;486(1-2):153-8. doi: 10.1016/j.ijpharm.2015.03.038. Epub 2015 Mar 18. Int J Pharm. 2015. PMID: 25796123

3

Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of Cefixime.

Imran M, Shah MR, Ullah F, Ullah S, Elhissi AM, Nawaz W, Ahmad F, Sadiq A, Ali I. Imran M, et al. Among authors: elhissi am. Int J Pharm. 2016 May 30;505(1-2):122-32. doi: 10.1016/j.ijpharm.2016.03.042. Epub 2016 Apr 2. Int J Pharm. 2016. PMID: 27050867

4

Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.

Najlah M, Kadam A, Wan KW, Ahmed W, Taylor KM, Elhissi AM. Najlah M, et al. Among authors: elhissi am. Int J Pharm. 2016 Jun 15;506(1-2):102-9. doi: 10.1016/j.ijpharm.2016.04.027. Epub 2016 Apr 20. Int J Pharm. 2016. PMID: 27107899 Free article.

5

Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.

Ullah S, Shah MR, Shoaib M, Imran M, Elhissi AM, Ahmad F, Ali I, Shah SW. Ullah S, et al. Among authors: elhissi am. Drug Deliv. 2016 Nov;23(9):3480-3491. doi: 10.1080/10717544.2016.1196768. Epub 2016 Jul 16. Drug Deliv. 2016. PMID: 27247018 Free article.

6

Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.

Imran M, Shah MR, Ullah F, Ullah S, Elhissi AM, Nawaz W, Ahmad F, Sadiq A, Ali I. Imran M, et al. Among authors: elhissi am. Drug Deliv. 2016 Nov;23(9):3653-3664. doi: 10.1080/10717544.2016.1214991. Epub 2016 Nov 25. Drug Deliv. 2016. PMID: 27886514 Free article.

7

Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation.

Khan I, Yousaf S, Subramanian S, Albed Alhnan M, Ahmed W, Elhissi A. Khan I, et al. Among authors: elhissi a. Int J Pharm. 2018 Mar 1;538(1-2):250-262. doi: 10.1016/j.ijpharm.2017.12.049. Epub 2018 Jan 12. Int J Pharm. 2018. PMID: 29337185 Free article.

8

Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment.

Najlah M, Said Suliman A, Tolaymat I, Kurusamy S, Kannappan V, Elhissi AMA, Wang W. Najlah M, et al. Among authors: elhissi ama. Pharmaceutics. 2019 Nov 14;11(11):610. doi: 10.3390/pharmaceutics11110610. Pharmaceutics. 2019. PMID: 31739556 Free PMC article.

9

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines.

Said Suliman A, Khoder M, Tolaymat I, Webster M, Alany RG, Wang W, Elhissi A, Najlah M. Said Suliman A, et al. Among authors: elhissi a. Pharmaceutics. 2021 Jan 10;13(1):84. doi: 10.3390/pharmaceutics13010084. Pharmaceutics. 2021. PMID: 33435151 Free PMC article.

10

Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone.

Kawish M, Jabri T, Elhissi A, Zahid H, Muhammad Iqbal K, Rao K, Gul J, Abdullah M, Shah MR. Kawish M, et al. Among authors: elhissi a. Pharm Dev Technol. 2021 Mar;26(3):291-301. doi: 10.1080/10837450.2020.1866602. Epub 2021 Jan 25. Pharm Dev Technol. 2021. PMID: 33475034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters